MEN-10755
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MEN-10755, covering 2012-07-02 to 2012-07-24. Get the full timeline:
Most recent: Clinical Trial Update: MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]